The impact of menthol cigarette use on quit attempts and abstinence among smokers with opioid use disorder

Danusha Selva Kumar, Meghan Peterson, Chenshu Zhang, Pebbles Fagan, Shadi Nahvi

Research output: Contribution to journalArticlepeer-review

Abstract

An exceedingly high proportion of persons with opioid use disorder (OUD) smoke cigarettes. Smokers with OUD face multiple barriers to smoking cessation. While menthol cigarette use has been associated with low cessation rates, research has not explored the impact of menthol cigarette use on tobacco use outcomes among smokers with OUD. Participants were current smokers, in methadone treatment for OUD, participating in randomized controlled trials of smoking cessation therapies. We examined the use of menthol cigarettes, and the association between menthol cigarette use and achieving 24-hour quit attempts and seven-day point prevalence abstinence. Of 268 participants, 237 (88.4%) reported menthol use. A similar proportion of menthol and non-menthol smokers achieved a 24-hour quit attempt (83.1% vs. 83.8%, p = 0.92). Though fewer menthol smokers (vs. non-menthol smokers) achieved abstinence (12.7% vs. 22.6%), this did not reach statistical significance (p = 0.14). In this sample of smokers with OUD, menthol smoking was nearly ubiquitous. Menthol smoking was not associated with differences in quit attempts, but was associated with differences in cessation that were not statistically significant. Menthol smoking may contribute to the challenges in achieving abstinence among smokers with OUD.

Original languageEnglish (US)
Article number106880
JournalAddictive Behaviors
Volume118
DOIs
StatePublished - Jul 2021

Keywords

  • Menthol
  • Methadone
  • Opioid use disorder
  • Quit attempts
  • Smoking cessation
  • Tobacco abstinence

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Toxicology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The impact of menthol cigarette use on quit attempts and abstinence among smokers with opioid use disorder'. Together they form a unique fingerprint.

Cite this